Hatice Taşkan

Dr. Hatice Taşkan

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
SASerkan Asil
Serkan Asil
EMEnder Murat
Ender Murat
HTHatice Taşkan
Hatice Taşkan
VBVeysel Barış
Veysel Barış
SGSuat Görmel
Suat Görmel
CBCem Barçın
Cem Barçın
Introduction: The most important way to reduce CVD-related mortality is to apply appropriate treatment according to the risk status of the patients. For this purpose, the SCORE risk model is used in Europe. In addition to these risk models, some anthropometric measurements are known to be associated with CVD risk and risk factors. Objectives: This study aimed to investigate the association of these anthropometric measurements, especially neck circumference (NC), with the SCORE risk chart. Methods: This was planned as a cross-sectional study. The study population were classified according to their SCORE risk values. The relationship of NC and other anthropometric measurements with the total cardiovascular risk indicated by the SCORE risk was investigated. Results: A total of 232 patients were included in the study. The patients participating in the study were analysed in four groups according to the SCORE ten-year total cardiovascular mortality risk. As a result, the NC was statistically significantly lower among the SCORE low and moderate risk group than all other SCORE risk groups (low-high and very high 36(3)–38(4) (IQR) p: 0.026, 36(3)–39(4) (IQR) p < 0.001, 36(3)–40(4) (IQR) p < 0.001), (moderate-high and very high 38(4) vs. 39(4) (IQR) p: 0.02, 38(4) vs. 40(4) (IQR) p < 0.001, 39(4) vs. 40(4) (IQR) p > 0.05). NC was found to have the strongest correlation with SCORE than the other anthropometric measurements. Conclusions: Neck circumference correlates strongly with the SCORE risk model which shows the ten-year cardiovascular mortality risk and can be used in clinical practice to predict CVD risk.

26 February 2025 in Biomarkers in Medicine
Verified
Journal Article
Closed access
DIDOGAN ILIS
DOGAN ILIS
AAAyça Arslan
Ayça Arslan
IAinanc artac
inanc artac
MKMuammer Karakayalı
Muammer Karakayalı
TOTimor Omar
Timor Omar
IRIbrahim Rencüzoğulları
Ibrahim Rencüzoğulları
We aimed to investigate the association between the HALP score and in-hospital mortality in patients with non-ST segment myocardial infarction (NSTEMI). In this retrospective study participants were divided into two groups, based on the median HALP score. Findings were compared between the groups. A total of 1648 patients included. The median HALP score cutoff value was 3.87. While the low HALP score group (3.87) included 824 patients. Patients with the low HALP score were older and had a higher prevalence of comorbidities. A HALP score ≤ 2.62 predicted in-hospital mortality with sensitivity of 72.5% and a specificity of 77.3% (area under curve 0.809), according to ROC curve analysis. In multivariate analysis, age, diastolic blood pressure, Killip Class > 1 and Syntax Score, creatinine level, LVEF and HALP Score (OR: 0.504, 95% CI: 0.415-0.613; p < 0.001) were independently associated with in-hospital mortality. According to the current study, the HALP score was independently associated with in-hospital mortality in patients with NSTEMI. Moreover, HALP score might be used as a predictor of in-hospital mortality in this population.

6 December 2022 in Sleep and Vigilance
Verified
Journal Article
Closed access
PDF file
MKMustafa Koklu
Mustafa Koklu
AYAhmet Faruk Yagci
Ahmet Faruk Yagci
PCPelin Mese Coskun
Pelin Mese Coskun
HTHatice Taşkan
Hatice Taşkan
SYSalim Yasar
Salim Yasar
MCMurat Celik
Murat Celik

1 July 2021 in The Anatolian Journal of Cardiology
Verified
Journal Article
Open access
SGSuat Gormel
Suat Gormel
SYSalim Yasar
Salim Yasar
SASerkan Asil
Serkan Asil
EYErkan Yildirim Yildirim
Erkan Yildirim Yildirim
SFSerdar Firtina
Serdar Firtina
ATAnkara- Turkey
Ankara- Turkey
Objective: The management of severe functional mitral regurgitation (FMR) in patients with heart failure (HF) and low ejection fraction is controversial, but percutaneous transcatheter procedures are promising. In this retrospective analysis, we aimed to assess the efficacy of the Carillon Mitral Contour System in patients with "inoperable" severe FMR. Methods: Seventy three patients (mean age 66.89, range 31-90 years) with congestive heart failure (CHF), severe FMR, and reduced ejection fraction (<35%) who underwent Carillon device implantation were examined. The study group consisted of patients with successfully implanted devices whereas the control group comprised patients in whom the device could not be deployed. The primary endpoint was combined allcause mortality and first hospitalization for HF (whichever came first). Results: The median (Q1, Q3) follow-up was 31 (11-49) months. The device was deployed successfully in 50 patients (implant group) and not in 23 patients (non-implant group). Both the primary endpoint and all-cause mortality were lower in the "implant" group, but the differences were not significant. The median to primary endpoint was 21 [95% confidence interval (CI) 8.8-33.2] and six (95% CI 0.1-11.9) months for the implant group and the non-implant group, respectively (p=0.078). Conclusion: Carillon Mitral Contour System implantation is a safe procedure and results in the reduction of all-cause mortality and combined endpoint of mortality and hospitalizations for HF in inoperable patients with severe FMR and low ejection fraction, although the difference did not meet the significance level.

5 March 2025 in medRxiv
Verified
Preprint
Open access
PDF file
SESelen Eski
Selen Eski
HTHatice Taşkan
Hatice Taşkan
PCPelin Meşe Coşkun
Pelin Meşe Coşkun
SASanan Allahverdiyev
Sanan Allahverdiyev
ŞKŞeymagül Karaca
Şeymagül Karaca
MÇMurat Çelik
Murat Çelik
Aim: This study aimed to investigate the effect of carotid body size on target organ damage in patients with hypertension and its potential association with relevant parameters. Method: A total of 49 participants diagnosed with hypertension or newly diagnosed hypertension, who were admitted to the outpatient clinic between January 2023 and April 2024, were included in the study. The size of the carotid body was measured using computed tomography. The study population was categorized into two groups based on a carotid body size threshold of 2.5 mm. Transthoracic echocardiography was performed, and blood pressure measurements and pulse wave analyses were examined non-invasively. Results: The mean age of the participants was 54.93 ± 10.85 years, and 36.7% (n=18) were male. In the group with a larger carotid body size, the left atrial diameter, total vascular resistance, and pulse-adjusted augmentation index (AIx@75) were higher, while the left atrial strain values and cardiac index were lower compared to those in the group with a smaller carotid body size (p <0.05). Multivariate linear regression analysis and ROC analysis were performed to determine the parameters that were significantly associated with carotid body size, and it was revealed that left atrial diameter (AUC: 0.794 (0.667-0.920), p<0.001) and total vascular resistance (AUC: 0.819 (0.700-0.938), p<0.001) were independently associated with carotid body size. Conclusion: This study suggests that processes leading to carotid body enlargement or those caused by this enlargement in patients diagnosed with hypertension, may affect parameters such as left atrial diameter, left atrial strain, AIx, and total vascular resistance, which could serve as indicators of target organ damage.

1 December 2022 in Gulhane Medical Journal
Verified
Journal Article
Closed access
HTHatice Taşkan
Hatice Taşkan
EMEnder Murat
Ender Murat
ÖEÖzkan Eravcı
Özkan Eravcı
MKMehmet Sadık Karpat
Mehmet Sadık Karpat
OKOzan Köksal
Ozan Köksal
MÇMurat Çelik
Murat Çelik